treatment with alpha-difluoromethylornithine ( dfmo ) , an enzyme-activated irreversible inhibitor of ornithine decarboxylase ( odc ) , depletes the putrescine and spermidine content , and reduces the growth rate of ehrlich ascites tumor cells .
C0034170
putrescine
C0037871
content